Skip to content

HIV-Related Symptom Screening Panel (Serum/Plasma)

Published: August 9, 2026Updated: August 16, 2026

This test evaluates markers linked to infections or immune-related symptoms possibly associated with HIV. It helps assess your body’s response to viral activity or treatment effects.

Quick summary

["This screening helps identify signs of infection or immune changes tied to HIV, guiding further care."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
47244-9
Short code
Symptom, Dx, or infect related to HIV Rx
Synonyms
Symptom, Dx, or infect related to HIV Rx
Category
coagulation
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Ref low
0.8
Ref high
1.2
Critical range
— – 5 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
reported
CPT
85610
SNOMED
396252006
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test may include measurements of immune system activity (e.g., markers of inflammation or immune cell function) and substances that reflect infection or treatment response. Some tests may also check for viral load indicators indirectly.

Why It’s Done

Your healthcare provider may order this test if you have symptoms like fatigue, fever, or unexplained weight loss that could relate to HIV or its treatment. It helps monitor your health during active infection or while on antiretroviral therapy.

Common Analytes Included

While the exact tests vary by lab, this panel often includes general immune or inflammatory markers (e.g., certain cytokines, white blood cell counts, or proteins that signal immune response). Some tests may measure substances like antibodies or fragments of viruses.

What to Expect Before the Test

No special preparation is needed unless instructed by your provider. You’ll typically provide a blood sample drawn from a vein in your arm.

Reference range

INR: 0.8-1.2 (warfarin: 2.0-3.0)N/A

Specimen: serum

Inform your healthcare provider if you are taking blood thinners. No special preparation required.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

HIV Symptom Check

Frequently asked questions

How might these results affect my care?
Results may help determine if your symptoms stem from HIV-related infection, immune dysfunction, or other conditions. Elevated markers could signal active infection or immune stress, prompting adjustments to treatment or further testing.
Can this test replace an HIV viral load test?
No, this panel is a general screening tool for symptoms/infection markers. A dedicated HIV viral load test measures the exact amount of virus in your blood, which is critical for treatment decisions.
What if my results are abnormal?
Abnormal results may require additional tests or follow-up with your provider to explore causes like infection, side effects of treatment, or other health concerns. They’ll discuss next steps with you.
  1. 1
    MedlinePlus — Laboratory TestsSource
  2. 2
    Lab Tests OnlineSource
  3. 3
    Mayo Clinic — Tests & ProceduresSource

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy